I believe He saved me for a reason.

This is why I think He did it.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

I was never supposed to be President. Friend, I was never supposed to survive the bullet of an assassin, BUT I DID. I was never supposed to be President of the United States again, BUT I AM. I was never supposed to Make America Great Again, BUT I WILL NEVER SURRENDER! The great behemoth known as the Democrat Party threw everything at me: Hoaxes, Witch Hunts, Impeachments, Election Interference, Raids, Arrests, and so much more! But the steady compass of Faith has guided my hands through it all. NOW, the government is completely shut down, and they think MAGA IS DONE. We can't take our foot off the gas! I was saved for this one reason: to Make America Great Again. I was made for this, BUT MAGA IS POWERED BY YOU. That's why I've launched a 24 HOUR TRUMP FUNDRAISING BLITZ, and I'm asking everyone to chip in $15 to make it one for the record books! Every time they count us out – count YOU out – we come back bigger, better, and stronger than ever before. This is our moment to show the world that we will NEVER back down, NEVER give an inch, and NEVER SURRENDER in our fight to save this country. So if you're with me all the way to the end, join with MILLIONS of your fellow PATRIOTS by chipping in $15 to keep the wins rolling in! > GIVE $15 STAND WITH TRUMP May God Bless you, Donald J. Trump President of the United States STAND WITH TRUMP Paid for by Never Surrender, Inc. Not authorized by any candidate or candidate authorized's committee. www.donaldjtrump.com. P.O. BOX 13570 ARLINGTON, VA 22219 Click here to unsubscribe or change your subscription status. Privacy Policy

Last week's stock pick was quite popular...

Make this one trade on Monday afternoon...and you'll be thanking me Tuesday morning. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­

Greetings, 

Every Monday afternoon, we send out a stock trade idea to some of MarketBeat's best and most valued subscribers.

We think you are one of those people...but you are not on our alert distribution list yet. 

This once a week alert is sent out via SMS so that you can see it right away. 

Last week's alert was very popular with our subscribers, you won't want to miss out on the next alert -- and it doesn't cost you a thing.

We're going to send out another trade idea on Monday around noon, and I want to make sure that you're able to see it.

Add your name to the distribution list here.

You'll thank me on Tuesday morning.

Matthew Paulson
MarketBeat

Add your name to the list

 
 
 
 
 
 

---

Today's Featured Story

CVS Health Gains as Revenue Grows, Dividend Remains Strong

Written by Gabriel Osorio-Mazilli. Published 9/25/2025.

Key Points

• CVS has broken past 52-week highs, and this newfound optimism is likely to carry the stock even higher in the coming quarters.
• With strong financials and fundamentals, seeing Wall Street analysts raise their price targets makes sense.
• Institutions are also buying in on this momentum play with an attractive dividend payout.

One of the best ways for any investor to lock in additional portfolio upside is to start exploring areas where few others are willing to venture—especially the least popular corners of the market.

In the consumer staples sector, one typically quiet company is now breaking out to new 52-week highs—and the trend could persist.

Shots officially fired… (Ad)

Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the rights to deliver direct-to-cell service nationwide — a move tech analyst Jeff Brown says could shape the backbone of the coming space economy and create fortunes on a scale not seen since the rise of NVIDIA.

Click here to watch Jeff's urgent briefing

Shares of CVS Health Corp. (NYSE: CVS) have been among the top performers in the space, in part because its market share is growing as its closest rival, Walgreens Boots Alliance Inc. (NASDAQ: WBA), continues to cut back on physical locations each quarter.

That open field may explain some of the bullishness, but investors are also digging into CVS's underlying financials to see where the company could expand in the quarters ahead. Today's enthusiasm could be just the start of CVS's upside potential.

Additionally, steady, predictable names like CVS may become even more attractive now that Federal Reserve Chair Jerome Powell has characterized stocks as "highly valued" assets.

Newfound Optimism for CVS Stock

This $96.8 billion company has room to grow, and its new 52-week high suggests the market is pricing in that potential. Year to date, CVS shares have rallied more than 70%, but there are fundamental reasons this momentum could continue.

A chorus of institutional investors, led by Ameriprise Financial, increased their holdings by 5.2% as of August 2025, bringing their stake to $565.4 million. That follows $3.3 billion in institutional buying of CVS stock over the past quarter alone.

There's more than technical momentum at work. Barclays analyst Andrew Mok recently raised his price target on CVS to a new high of $87 per share, implying 14% more upside and the potential for another new 52-week high.

That target stands well above the $78.25 consensus, underscoring how bullish some analysts have become on CVS's outlook.

Strong Financials Boost Shareholder Confidence

Management knows that growing market share amid competitor contraction creates an opportunity to reward shareholders. CVS now pays $2.66 in dividends per share annually, which translates to a 3.5% yield—above current U.S. inflation rates.

Here's the latest on CVS's fundamentals:

In its most recent quarter, CVS reported EPS of $1.81, 24% above the MarketBeat consensus of $1.46, setting the stage for continued outperformance.

According to the company's press release, net revenues came in at $98.9 billion, an 8.4% increase from a year earlier—no small feat in a traditionally steady sector.

CVS's strong ties to government health programs have helped offset medicine and service inflation, allowing the company to reinvest in technology and streamline connections between caregivers and patients. That, in turn, reinforces its growing market share.

Investors can gauge the sustainability of these investments—and the dividend—by watching free cash flow (operating cash flow minus capital expenditures). With $185.1 billion in free cash flow, CVS has ample capacity to maintain and potentially grow its dividend program.

All of these factors—market share gains, analyst upgrades, solid earnings, and robust cash flow—position CVS for another potential earnings beat in the coming quarters, making it a less-crowded stock with attractive upside for investors.

 

Thank you for subscribing to MarketBeat!
 
We empower everyday investors to make better financial decisions by offering real-time financial information and objective investment research.
 
This email communication is a sponsored email sent on behalf of MarketBeat Alerts, a third-party advertiser of MarketBeat. Why did I receive this email?.
 
If you have questions about your subscription, feel free to email our South Dakota based support team at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2025 MarketBeat Media, LLC.
345 N Reid Pl., Suite 620, Sioux Falls, SD 57103-7078. United States of America..

 

Today's Featured Content: Own the AI Decision Layer Powering Fortune 1000s (From RAD Intel)

Top Gold Stocks to Watch as Gold Hits New Highs

4 Gold Stocks for the Next Leg of This Rally

Dear Reader, Gold just blasted to fresh record highs — $3,866.90 per ounce as of September 30, 2025 — extending a blistering run that's now up roughly 45% year-to-date.   Global trade tensions, a softer U.S. dollar, and renewed institutional demand — plus heavy central-bank buying — are fueling this historic rally.   That momentum has Wall Street raising the stakes: Goldman Sachs and J.P. Morgan now expect gold at $4,000 in mid-2026.   This creates a powerful setup for gold stocks — not just as a hedge, but as an opportunity for breakout growth as miner earnings and sentiment catch up to the metal's surge.   That's why we've published a FREE report profiling 4 gold stocks with outsized upside potential in the current environment.   Click below to claim the report and position yourself before the next leg of this historic run.   👉 Click here to access your Top 4 Gold Stocks Report now.   To Your Trading Success, The Financial Newsletter Team (By clicking the links above, you agree to receive future emails from us and bonus subscriptions from our partners. You can opt out at any time. – Privacy Policy)

Advertising Disclosure: This email contains paid advertisements. This email is from our associates at The Financial Newsletter. Legal Entity Information: Investment News Daily is owned and operated by Darwin Investor Network, a DBA of The Darwin Agency, Inc. Disclaimer: Nothing in this email should be considered personalized financial advice. Always conduct your own due diligence when investing. We urge you to read our full disclaimer by clicking on the terms of use link below. Unsubscribe: You are receiving this email as part of your complimentary subscription to the Investment News Daily E-Letter. If you would like to unsubscribe, you can do so by clicking on the unsubscribe link below. Darwin Investor Network 2319 N Andrews Avenue, Fort Lauderdale, FL 33311 support@investmentnewsdaily.com | 1-800-496-9838 Investment News Daily | Privacy Policy | Terms of Use Unsubscribe | View Online

Plan de paz entre Israel y Hamás

Traducción cortesía del Departamento de Estado de los Estados Unidos Plan de paz entre Israel y Hamás DONALD J. TRUMP @realDonaldTrump 8 DE OCTUBRE DE 2025 18:51 horas Es para mí un gran orgullo anunciar que Israel y Hamás han logrado un acuerdo sobre la primera fase de nuestro plan de paz. Ello significa que TODOS los rehenes serán liberados muy pronto y que Israel retirará sus tropas hasta una línea acordada, como primeros pasos hacia una paz sólida, duradera y perdurable. ¡Todas las partes recibirán un trato justo! Este es un GRAN día para el mundo árabe y musulmán, para Israel, para todas las naciones vecinas y para los Estados Unidos de América, y agradecemos a los mediadores de Catar, Egipto y Turquía, que trabajaron con nosotros para hacer posible este acontecimiento histórico y sin precedentes. ¡BIENAVENTURADOS LOS QUE PROCURAN LA PAZ! DONALD J. TRUMP PRESIDENTE DE LOS ESTADOS UNIDOS DE AMÉRICA Para ver el texto original, ir a: https://truthsocial.com/@realDonaldTrump/posts/115340993884364431  Esta traducción se proporciona como una cortesía y únicamente debe considerarse fidedigna la fuente original en inglés.

---

Actualice sus suscripciones, cambie su contraseña o dirección de correo electrónico, o cancele suscripciones en cualquier momento a través de su Página de Preferencias de Suscripción. Deberá usar su dirección de correo electrónico para iniciar sesión.

Si tiene preguntas o inconvenientes relacionados con el servicio de suscripción, visite subscriberhelp.govdelivery.com.

This email was sent to stevenmagallanes520.nims@blogger.com using GovDelivery Communications Cloud on behalf of: Department of State Office of International Media Engagement · 2201 C Street, NW · Washington, DC · 20520

We're excited to have you on board

We'll be sending you the latest buy and sell ratings from Wall Street's top analysts, but first, this... ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ Unsubscribe Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inbox Gmail users: Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users: Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers: Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscription Click this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey.   Matthew Paulson Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.       Just For You October's Top 5 Stocks Poised for Big Breakouts Written by Thomas Hughes. Published 10/1/2025. Key Points September was a strong month for the market, with names like Oklo, Amprius, and CrowdStrike moving higher. Improving outlooks for growth and profits drive these markets.  Analyst trends are driving them higher with new highs expected for most before the end of the year. September wasn't just hot on the calendar—it was a breakout period for the stock market. A wave of renewed optimism and stronger outlooks lifted the S&P 500 to fresh all-time highs, led by a handful of standout companies. With the year's final quarter underway, investors are asking which stocks can sustain this rally and deliver further gains. This review spotlights five names with improving fundamentals, rising analyst sentiment, and clear catalysts to build on recent momentum. From energy innovation to enterprise AI and cybersecurity, these stocks show why September's surge may only be the start. Oklo Cools Off, Pulls Back Into Buying Opportunity From Deloitte's #1 to IPO Watch (Ad) People spend 30 hours a week on their smartphones. And Mode has unlocked 19 ways to profit from it. Deloitte called them the #1 fastest-growing software company in North America in 2023 — and accredited investors can still get in while the opportunity remains open. Join 56,000+ investors — invest at $0.50/share today! Oklo (NYSE: OKLO) hit a peak in late September before pulling back into what looks like a buying opportunity. This retracement reflects caution after a triple-digit summer run-up—not any deterioration in the company's outlook. In fact, Oklo's deal pipeline continues to expand, and its path to commercial viability is becoming clearer (source). Analyst coverage has improved significantly over the past six months: no price targets have been cut, while the consensus target jumped 26% in the last 30 days and more than 700% year-over-year. Amprius Technologies: Similar Pullback, Buying Opportunity Amprius Technologies (NYSE: AMPX) mirrors Oklo's pattern but is already generating revenue—ramping at a hyper pace and set to report another strong quarter (source). After hitting a long-term high in September, AMPX entered a consolidation at month's end, holding support above its former resistance. The upcoming earnings release—forecast to show 10% sequential and 110% year-over-year revenue growth—could be the catalyst for new highs before year-end. Workday Poised to Reach New Highs Workday (NASDAQ: WDAY) struggled in recent years as much of its growth had been priced in and the outlook felt uncertain. Now the company is regaining momentum thanks to AI and automation (source), reinforcing its position as a leading HR automation platform. September announcements to expand its ecosystem with new hyperscaler partnerships should deepen client penetration and integration with top enterprise SaaS services. Analysts have responded with increased coverage, an upgraded Moderate Buy consensus rating, and rising price targets steering WDAY toward the $300 level. Salesforce: Market Shift Creates Long-Term Opportunity Salesforce (NYSE: CRM) has underperformed despite double-digit growth, robust margins, and strong cash flow. Yet this industry-leading AI powerhouse remains deeply undervalued. Salesforce's cash flow strategy balances growth initiatives with capital return—through dividends and share buybacks—to reduce the share count and enhance returns (source). While CRM may not ignite a rapid spike, its valuation in early October suggests it could rise 50% or more over the next four to six quarters. CrowdStrike Reinvigorates Growth Outlook: Analysts Respond Favorably CrowdStrike (NASDAQ: CRWD) jumped about 20% in September after outperformance, raised guidance, and new Salesforce partnerships (source). Analysts have expanded coverage to 47 tracked ratings, driving sentiment to a Moderate Buy. The consensus forecast suggests CRWD could climb as much as 25% over the next several quarters.   Thank you for subscribing to MarketBeat!   We empower everyday investors to make better investment decisions by delivering up-to-the-minute financial information and unbiased market analysis.   If you need assistance with your account, please feel free to email MarketBeat's South Dakota based support team at contact@marketbeat.com.   If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.   © 2006-2025 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, S.D. 57103-7078. USA..